Bavarian Nordic (BAVA CO) stock market data APIs
kr182.8378
-1.08(-0.6%)
as of March 9, 2026
Try our APIs with
free plan!
Bavarian Nordic Financial Data Overview
Price chart is built with
Anychart
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Prev. Close
182.8378
Open
181.7555
High
184.7455
Low
178.9897
52 wk Range
123.3-244.8
Market Cap
18 516 M
P/E Ratio
10.3887
Shares Outstanding
78 240 K
Revenue
6 455 M
Beta
1.096
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Bavarian Nordic (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bavarian Nordic data using free add-ons & libraries
Get Bavarian Nordic Fundamental Data
Bavarian Nordic Fundamental data includes:
- Net Revenue: 6 455 M
- EBITDA: 2 148 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bavarian Nordic News
New
Assessing Bavarian Nordic (CPSE:BAVA) Valuation After Recent Share Price Weakness
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Event driven snapshot Bavarian Nordic (CPSE:BAVA) recently...
Bavarian Nordic CEO to Step Down After $3 Billion Bid Fails
This article first appeared on GuruFocus. Bavarian Nordic A/S (BVNKF) is heading into another period of transition after Chief Executive Paul Chaplin said he will step down for personal reasons at th...
Paul Chaplin Steps Down as CEO of Bavarian Nordic
Bavarian Nordic A/S COPENHAGEN, Denmark, March 2, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today, that the Board of Directors has entered into an agreement with CEO, Paul Chaplin, who wishe...
Monkeypox Market Competitive Landscape 2026: Comprehensive Insights About 8+ Companies and 10+ Drugs
Company Logo Emerging opportunities in the monkeypox treatment and prevention market include innovative vaccine developments by companies such as Bavarian Nordic, BioNTech, and Moderna. The focus is ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
